Quince Therapeutics, Inc. (QNCX) — Cash Flow Quality Index
Latest as of March 2026:
-0.21x
Quince Therapeutics, Inc. (QNCX) has a Cash Flow Quality Index of -0.21x as of March 2026. Operating cash flow of $-7.63 Million is below net income of $35.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Quince Therapeutics, Inc. long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.21x
Operating CF / Net Income
Operating Cash Flow
$-7.63 Million
USD
Net Income
$35.91 Million
USD
Data as of
Mar 2026
Most recent filing
Annual Cash Flow Quality Index for Quince Therapeutics, Inc. (None–None)
Year-by-year earnings quality comparison for Quince Therapeutics, Inc.. For live market cap and the full company financial profile, see Quince Therapeutics, Inc. market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.